1TB.F - Orphazyme A/S

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Currency in EUR

Valuation measures4

Market cap (intra-day) 5.21M
Enterprise value -1.43M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.74
Price/book (mrq)0.34
Enterprise value/revenue -0.04
Enterprise value/EBITDA 0.00

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 3-3.44%
S&P500 52-week change 32.54%
52-week high 30.3400
52-week low 30.0848
50-day moving average 30.1260
200-day moving average 30.1342

Share statistics

Avg vol (3-month) 311
Avg vol (10-day) 3N/A
Shares outstanding 535.31M
Implied shares outstanding 6N/A
Float 825.8M
% held by insiders 11.36%
% held by institutions 17.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-22.28%
Return on equity (ttm)-150.23%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.03M
Net income avi to common (ttm)-38.31M
Diluted EPS (ttm)-2.8300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)42.46M
Total cash per share (mrq)1.2
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.55
Book value per share (mrq)1.18

Cash flow statement

Operating cash flow (ttm)-117.94M
Levered free cash flow (ttm)-64.09M